Don't put a climate denier in White House: Clinton tells US

October 12, 2016

Washington, Oct 12: Challenging her rival Donald Trump's assertion that climate change is a hoax, Democratic presidential nominee Hillary Clinton has asked Americans not to risk putting a "climate denier" in the White House.

hc"We cannot risk putting a climate denier in the White House at all, that is absolutely unacceptable. We need a President who believes in science and who has a plan to lead America in facing this threat, creating good jobs and yes, saving our planet," she told her supporters yesterday at an election rally in Miami, Florida.

Clinton identified the US, Germany and China as the three countries which can be the clean energy superpower in the 21st century.

"The clean energy superpower of the 21st century are probably going to be either Germany, China, or us, and I want it to be us. And I want you to be part of making it us," she said as she detailed out her plans in this regard.

The 68-year-old ex-secretary of state was joined during her rally by former US Vice President and climate change leader Al Gore.

She argued that the US needs to accelerate the transition to a clean energy economy and create high paying jobs, building and installing more solar panels and wind turbines.

"Modernising electric grid, retrofitting buildings, building resilient, 21st century infrastructure, and the US has to make sure no community is left out or left behind.

"Now, you wouldn't know it if you only listened to my opponent talk about how terrible everything is," she said lashing out at her 70-year-old opponent.

"He has such a dark, divisive view of America, but that doesn't tell the story about what's really going on. It's actually pretty exciting. In red states and blue states, local leaders are stepping up," she said.

"Rural electric co-ops are investing in community solar power and you see that across America, union workers in Michigan, union workers in Michigan, are getting ready to build electric Chevys in a plant powered by clean energy. Iowa is already getting a third of its electricity from wind," she added.

"Wind turbines are going up in New England and on Lake Erie. Renewable energy is already the fastest-growing source of new jobs in America. I think that is so exciting. There are nearly two million people already working in energy efficiency," she noted.

Clinton said as President, she wants the US to have 500 million solar panels installed across America by the end of her first term. "And let's generate enough renewable energy to power every home in America within the decade. Let's make our buildings and factories more energy efficient and cut our oil consumption by one-third," she said.

"And we can get there by investing in cutting edge research to keep developing cheaper and better clean energy technologies, investing in clean energy infrastructure and advanced manufacturing, putting big partnerships together between states, cities and rural communities," she added.

"Donald Trump is, quote, 'not a big believer' in climate change. As I said, he said it's a hoax created by the Chinese. And in our first debate two weeks ago, he tried to deny saying that. But that tweet is still there for everyone to see," Clinton said referring to a tweet by the real estate baron in 2012.

Addressing the meeting, Al Gore asserted that with Clinton in the White House, the US will build on the progress made under Barack Obama with the Paris Agreement and she will seize the opportunities. "After all, solar electricity and wind electricity is now way cheaper than it was years ago when some of us started sounding the alarm about this crisis," he said.

"Almost 100 years ago, America's most famous inventor, Thomas Edison said these words -– it's an exact quote: 'I would put my money on the sun and solar energy. What a source of power. I hope we don't have to wait until the oil and coal come out before we tackle that.' Now, I want to say a brief word -– I'm going to return to my second main point here in a minute, but I want to say a brief word about something else that all of you can do. You can elect Patrick Murphy to the United States Senate instead of a climate denier," Gore said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 28,2020

Canadian researchers are developing a DNA vaccine for SARS-CoV-2, the coronavirus that causes COVID-19 and has currently infected nearly 5,00,000 people worldwide and crippled the global economy.

Entos Pharmaceuticals, a health-care biotechnology company headed by a University of Alberta researchers, develop new therapeutic compounds using the company's proprietary drug-delivery platform and has begun manufacturing vaccine candidates against the novel coronavirus.

"Given the urgency of the situation, we can have a lead candidate vaccine within two months. Once we have that it's a race to get it into clinical trials," said John Lewis, CEO of Entos and a Professor at the University of Alberta in Canada.

Lewis said in comparison to a traditional vaccine, DNA-based vaccines hold several advantages.

Nucleic acids are introduced directly into the patient's own cells, causing them to make pieces of the virus--tricking the immune system into mounting a response without the full virus actually being present, the researcher said.

According to the company, the approach is recognised as being easier to move into large-scale manufacturing, offers improved vaccine stability and works without needing an infectious agent.

In the current absence of a vaccine for COVID-19, several companies around the world are mounting efforts to begin similar work.

The first clinical trial using a DNA-based vaccine developed by Moderna Inc.in the US on March 13.

Their approach allows for antibodies to be made in the human trial volunteers against a specific protein on the surface of the coronavirus that lets the virus enter human cells.

The hope is that the antibodies will stop the interaction.

Though this approach is designed to be effective against COVID-19 specifically, Lewis said Entos is taking a different tack.

The company plans to use plasmid DNA to amplify the production of key coronavirus surface and structural proteins with each injection, with an eye to the bigger picture.

"Many of the structural proteins in the virus are pretty well conserved across all the coronaviruses, including SARS and MERS," said Lewis.

"We're hoping that if we express more of the structural proteins that are common to most coronaviruses, we can inhibit the current COVID-19, and also potentially protect against all coronaviruses both past and future," Lewis added.

To move the project forward quickly, the company is seeking financial support from both provincial and federal levels of government.

"We have the opportunity to save a lot of lives, and I think it's really upon us and governments to find solutions for that," Lewis said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 21,2020

New Delhi, Feb 21: Global terror financing watchdog FATF on Friday decided continuation of Pakistan in the "Grey List" and warned the country that stern action will be taken if it fails to check flow of money to terror groups like the LeT and the JeM, sources said.

The decision has been taken at the Financial Action Task Force's plenary in Paris.

The FATF decided to continue Pakistani in the "Grey List". The FATF also warned Pakistan that if it doesn't complete a full action plan by June, it could lead to consequences on its businesses, a source said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.